Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Ofer Merimsky
41 years of experience
accreditations :
Clinic is certified :
Why choose Israel for CyberKnife treatment for lung cancer?
Access advanced CyberKnife for lung cancer solutions in trusted clinics .
| Israel | Turkey | Austria | |
| CyberKnife for lung cancer | - | from $6,000 | - |
No hidden fees – just official clinic prices. Pay at the clinic for CyberKnife for lung cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in CyberKnife for lung cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your CyberKnife for lung cancer journey.
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - CyberKnife Treatment
Day 4 - Post-Operation
Week 1 - Rehabilitation
Week 2 - Rehabilitation
Week 3 - Rehabilitation
Note that each patient"s journey is unique, and the timeline may vary based on individual needs and response to treatment.
As the leading global medical tourism platform, we have huge responsibility before our clients — both patients and medical centers. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services for CyberKnife for lung cancer and follows in Israel there.
Our experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic — so everyone on the platform can trust the facility they choose. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews for CyberKnife for lung cancer in Israel, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com you may find choice and convenience to find the best medical solutions from top medical services providers just in one place, and often at competitive prices for CyberKnife for lung cancer and follows in Israel. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation for CyberKnife for lung cancer in Israel. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com, please feel free to contact us at marketing@bookimed.com.
Dr. Ari Raphael leads pioneering lung cancer research with 5+ clinical trials as primary investigator, including advanced genomic profiling techniques at Sourasky Medical Center.
Head of the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – specializes in advanced lung cancer treatments including CyberKnife.
Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.
Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.
CyberKnife for lung cancer is a non-invasive treatment using precision radiation therapy to target tumors.
CyberKnife is a non-invasive robotic radiosurgery system that treats lung cancer using Stereotactic Body Radiation Therapy (SBRT). It delivers high-dose radiation from hundreds of angles with sub-millimeter precision. A robotic arm tracks tumor motion in real-time, allowing patients to breathe naturally without invasive immobilization devices.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center (Ichilov) utilize advanced Novalis TrueBeam STx alongside CyberKnife. While CyberKnife is famous for tracking, TrueBeam can deliver similar SBRT doses faster. Choosing between them often depends on tumor size. Small tumors under 3 cm are ideal for CyberKnife's robotic precision. Centers in Israel serve 40,000+ cancer patients annually, specializing in these high-tech radiation alternatives.
Patient Consensus: Patients value that this is robotic radiosurgery rather than an actual knife. While side effects like fatigue occur, the ability to avoid restrictive chest devices during treatment is a major relief.
CyberKnife for lung cancer in Israel achieves a 90% to 97% local control rate, meaning tumors stop growing or shrink. This non-invasive treatment offers a 3-year survival rate up to 91% for early-stage patients who cannot undergo traditional surgery.
Bookimed Expert Insight: Israeli centers like Sourasky Medical Center leverage advanced TrueBeam STx technology to provide precision radiotherapy. While marketing often cites 90% success, clinical data confirms surgery remains the gold standard for fit patients. CyberKnife is best utilized as a high-precision alternative for inoperable cases or localized thoracic tumors.
Patient Consensus: Patients value the immediate return to daily activities and the lack of anesthesia. Many choose this route to avoid the risks of invasive surgery while maintaining high survival outcomes.
Ideal CyberKnife candidates in Israel include patients with small, well-defined tumors that are surgically inoperable or located near critical organs. This non-invasive robotic radiosurgery is highly effective for early-stage lung cancer, localized prostate cancer, and small metastatic brain or spinal tumors requiring sub-millimeter precision.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center treat 40,000 cancer patients annually, often using the Novalis TrueBeam STx. While patients often request CyberKnife by name, specialists like Dr. Ofer Merimsky may recommend TrueBeam for similar precision. Both platforms deliver Stereotactic Body Radiation Therapy (SBRT), providing curative results for early-stage lung cancer without the brand-specific price premium.
Patient Consensus: Many patients find this an ideal curative option when traditional surgery is too risky. They emphasize confirming clinical SBRT eligibility rather than focusing solely on the specific machine brand.
CyberKnife for lung cancer in Israel typically causes minimal side effects because stereotactic radiosurgery uses sub-millimeter precision to spare healthy lung tissue. Most patients experience only mild fatigue, though delayed effects like radiation pneumonitis may appear several weeks after the non-invasive procedure.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center treat 40,000 cancer patients annually using high-precision TrueBeam STx technology. Data suggests that clinics combining genomic testing, such as Foundation One CDx, with radiosurgery better manage patient outcomes. This precision reduces the physical toll compared to traditional surgery or conventional radiation therapies.
Patient Consensus: Patients report that side effects are significantly less severe than conventional radiation, with many experiencing zero discomfort. Most characterize the recovery as manageable, noting that fatigue is often the only noticeable physical challenge.
CyberKnife treatment for lung cancer in Israel typically requires 1 to 5 sessions. This hypofractionated radiation approach delivers high-dose precision therapy over 1 to 2 weeks. It serves as a non-invasive alternative to surgery for patients with early-stage tumors or those unfit for invasive procedures.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center utilize the Novalis TrueBeam STx technology. This system allows doctors like Dr. Ofer Merimsky to treat tumors with sub-millimeter precision. This accuracy is why the 34,000 yearly operations at Sourasky maintain high safety levels. Patients often save up to _price_percent_discount_% compared to US costs for the same advanced technology.
Patient Consensus: Patients note the first session takes longer for alignment, but later visits are quick. Most feel relieved by the lack of side effects compared to traditional 30-session radiation protocols.
Preparing for treatment in Israel requires coordinating with a hospital international department, organizing medical records, and securing an entry invitation. Leading centers like Sourasky Medical Center provide specialized care for lung cancer using non-invasive technologies like CyberKnife, which typically requires 1–5 outpatient sessions.
Bookimed Expert Insight: Israeli oncology centers often integrate genomic profiling, such as Foundation One CDx, directly into lung cancer protocols. This allows surgeons to determine if CyberKnife or targeted immunotherapy is more effective for your specific tumor markers before you even arrive in Tel Aviv.
Patient Consensus: Verify that your tumor is under 3 cm to ensure maximum effectiveness with CyberKnife technology. Patients recommend sleeping propped up on pillows for two days post-treatment to manage any potential chest swelling.
Israeli medical centers like Sourasky Medical Center (Ichilov) and Sheba Medical Center provide CyberKnife and advanced Stereotactic Body Radiation Therapy for lung cancer. These JCI-accredited facilities utilize high-precision technologies like the Novalis TrueBeam STx to treat thoracic tumors non-invasively with high success rates.
Bookimed Expert Insight: Israeli oncology centers like Sheba and Ichilov handle massive patient volumes, treating up to 40,000 cancer patients annually. This high frequency allows surgeons to refine SBRT protocols, often resulting in shorter treatment cycles of 1–5 sessions. While the technology is advanced, the average cost of $17,500 maintains substantial value, saving you up to _price_percent_discount_% compared to US prices of _price_compare_US_average_.
Patient Consensus: Patients emphasize searching for hospitals using clinical terms like SBRT or SABR, which are the standard medical names for CyberKnife procedures. Many travelers recommend preparing medical files beforehand for direct specialist review during consultation.